A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
Dermatitis, Atopic
Interventions
DRUG

BMS-986166

Specified dose on specified days

DRUG

Branebrutinib

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (42)

2010

Holdsworth House Medical Practice, Sydney

2145

Westmead Hospital-Dermatology, Westmead

2217

Premier Dermatology, Kogarah

3002

Sinclair Dermatology, East Melbourne

4020

Local Institution, Linz

10029

Local Institution, New York

10117

Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin

12459

Local Institution, Berlin

14004

Local Institution - 0130, Córdoba

15213

Local Institution - 0094, Pittsburgh

19103

Local Institution - 0078, Philadelphia

20850

Dermatology and Skin Cancer Specialists, LLC, Rockville

24105

Universitatsklinikum Schleswig-Holstein, Kiel

26505

Local Institution - 0003, Morgantown

28046

Hospital Universitario La Paz-UCICEC/DERMA, Madrid

30625

Local Institution, Hanover

33014

Local Institution - 0006, Miami Lakes

33063

Local Institution - 0110, Margate

33134

Local Institution - 0061, Coral Gables

33511

Local Institution - 0112, Brandon

33613

Local Institution, Tampa

35010

Hospital Universitario de Gran Canaria Doctor Negrín-Dermatología, Las

40217

Local Institution - 0083, Louisville

44793

Local Institution - 0034, Bochum

46250

Local Institution - 0081, Indianapolis

49074

KliFOs - Klinische Forschung Osnabrück, Osnabrück

53127

Universitätsklinikum Bonn-Studienzentrum Dermatologie, Bonn

56242

Private Practice - Dr. Ralph von Kiedrowski, Selters

60077

Local Institution - 0008, Skokie

64506

Local Institution - 0051, Saint Joseph

77401

The University of Texas Health Science Center at Houston, Bellaire

78213

Local Institution, San Antonio

80337

Local Institution, Munich

94538

Local Institution - 0091, Fremont

L3P 1X2

Local Institution, Markham

L4C 9M7

York Dermatology Clinic and Research Centre, Richmond Hill

H4G 3E7

SIMa Recherche, Verdun

07548

SRH Wald-Klinikum Gera-Zentrum für klinische Studien, Gera

02-962

Royalderm Agnieszka Nawrocka, Warsaw

85-231

NZOZ Centrum Medyczne KERmed, Bydgoszcz

10-117

ETYKA Osrodek Badan Klinicznych, Olsztyn

03010

Hospital General Universitario de Alicante-Dermatology, Alicante

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05014438 - A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis | Biotech Hunter | Biotech Hunter